TipRanks
Go Ultimate55% OFF

Gland Pharma Ltd. (GLAND) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

GLAND Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Gland Pharma Ltd. in the past 3 months

GLAND Stock 12 Month Forecast

INR 3,350.00▲(8.15% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Gland Pharma Ltd. in the last 3 months. The average price target is INR 3,350.00 with a high forecast of INR 3,350.00 and a low forecast of INR 3,350.00. The average price target represents a 8.15% change from the last price of INR 3,097.50.
Highest Price TargetINR 3,350.00Average Price TargetINR 3,350.00Lowest Price TargetINR 3,350.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IN:GLAND
Price TargetFollowArticle
JefferiesINR 2,080→INR 3,350buy8.15%UpsideUpgraded08/11/26
ICICI SecuritiesINR 2,275buy-26.55%DownsideReiterated01/29/26
Axis Direct Analyst forecast on IN:GLANDUnknown AnalystNot RankedAxis DirectINR 2,170buy-29.94%DownsideReiterated01/29/26
Motilal Oswal Analyst forecast on IN:GLANDUnknown AnalystNot RankedMotilal OswalINR 2,050buy-33.82%DownsideReiterated01/28/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Gland Pharma Ltd.

3 Months
Alok Dalal
Alok DalalJefferies
Success Rate2/3 ratings generated profit
67%
Average Return
+7.47%

Copying Alok Dalal's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +7.47% per trade.

1 Year
Abdulkader Puranwala
Abdulkader PuranwalaICICI Securities
Success Rate2/2 ratings generated profit
100%
Average Return
+46.65%

Copying Abdulkader Puranwala's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +46.65% per trade.

2 Years
Abdulkader Puranwala
Abdulkader PuranwalaICICI Securities
Success Rate2/2 ratings generated profit
100%
Average Return
+52.55%

Copying Abdulkader Puranwala's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +52.55% per trade.

GLAND Analyst Recommendation Trends

01234Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for GLAND
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy00111
Hold11000
Sell00000
Strong Sell00000
total11111

In the current month, GLAND has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GLAND average Analyst price target in the past 3 months is 3,350.00.

GLAND Financial Forecast

INR 10INR 13.25INR 16.5INR 19.75INR 23Q3 2026Q1 2027Q2 2027
HighINR 17.70
ConsensusINR 16.73
LowINR 15.70

GLAND Earnings Forecast

Next quarter’s earnings estimate for GLAND is INR 16.73 with a range of INR 15.70 to INR 17.70. The previous quarter’s EPS was INR 19.22. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

INR 14.9BINR 15.7BINR 16.6BINR 17.5BINR 18.4BQ3 2026Q1 2027Q2 2027
HighINR 18.4B
ConsensusINR 17.7B
LowINR 17.3B

GLAND Sales Forecast

Next quarter’s sales forecast for GLAND is INR 17.73B with a range of INR 17.25B to INR 18.35B. The previous quarter’s sales results were INR 18.00B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

GLAND Stock Forecast FAQ

What is IN:GLAND’s average 12-month price target, according to analysts?
Based on analyst ratings, Gland Pharma Ltd.’s 12-month average price target is ₹3,350.00.
What is IN:GLAND’s upside potential, based on the analysts’ average price target?
Gland Pharma Ltd. has 8.15% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Gland Pharma Ltd. a Buy, Sell or Hold?
Gland Pharma Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Gland Pharma Ltd.’s share price target?
The average share price target for Gland Pharma Ltd. is ₹3,350.00. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is ₹3,350.00, and the lowest forecast is ₹3,350.00. The average share price target represents a 8.15% increase from the current price of ₹3,097.5.
What do analysts say about Gland Pharma Ltd.?
Gland Pharma Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Gland Pharma Ltd.?
To buy shares of IN:GLAND, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.